395 related articles for article (PubMed ID: 17227440)
1. Anandamide: an update.
Smita K; Sushil Kumar V; Premendran JS
Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
Fowler CJ
Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
[TBL] [Abstract][Full Text] [Related]
4. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
Chiba T; Ueno S; Obara Y; Nakahata N
J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids biology: the search for new therapeutic targets.
Felder CC; Dickason-Chesterfield AK; Moore SA
Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
[TBL] [Abstract][Full Text] [Related]
7. Psychopharmacology of the endocannabinoids: far beyond anandamide.
Pamplona FA; Takahashi RN
J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
[TBL] [Abstract][Full Text] [Related]
9. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
Pertwee RG
Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
[TBL] [Abstract][Full Text] [Related]
10. Mixed signals: cannabinoid system offers new therapeutic possibilities as well as challenges.
Shekhar C
Chem Biol; 2011 May; 18(5):553-4. PubMed ID: 21609833
[No Abstract] [Full Text] [Related]
11. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.
López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
Eur J Med Chem; 2003 Apr; 38(4):403-12. PubMed ID: 12750028
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system and pain.
Guindon J; Hohmann AG
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
[TBL] [Abstract][Full Text] [Related]
14. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
15. Anandamide and the vanilloid receptor (TRPV1).
Tóth A; Blumberg PM; Boczán J
Vitam Horm; 2009; 81():389-419. PubMed ID: 19647120
[TBL] [Abstract][Full Text] [Related]
16. Drug development. Drugs inspired by a drug.
Marx J
Science; 2006 Jan; 311(5759):322-5. PubMed ID: 16424309
[No Abstract] [Full Text] [Related]
17. Cannabimimetic plants: are they new cannabinoidergic modulators?
Kumar A; Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Memo M; Mastinu A
Planta; 2019 Jun; 249(6):1681-1694. PubMed ID: 30877436
[TBL] [Abstract][Full Text] [Related]
18. Fatty pain cures.
Imming P
Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
[TBL] [Abstract][Full Text] [Related]
19. "The tools of the trade"--an overview of the pharmacology of the endocannabinoid system.
Fowler CJ
Curr Pharm Des; 2008; 14(23):2254-65. PubMed ID: 18781976
[TBL] [Abstract][Full Text] [Related]
20. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.
Almeida V; Levin R; Peres FF; Suiama MA; Vendramini AM; Santos CM; Silva ND; Zuardi AW; Hallak JEC; Crippa JA; Abílio VC
Neuropharmacology; 2019 Sep; 155():44-53. PubMed ID: 31103618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
